Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2017

Feb 14, 2018

SELL
$131.06 - $150.39 $1.34 Million - $1.53 Million
-10,200 Reduced 78.46%
2,800 $377,000
Q3 2017

Nov 14, 2017

BUY
$142.62 - $155.6 $1.85 Million - $2.02 Million
13,000
13,000 $1.9 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.